Levels of β1-AR autoantibodies in all subjects were detected using ELISA to evaluate the effects of β1-AR autoantibodies on the percentages of B1 and Tr cells and clinical parameters of patients with DCM. This evidence concerns the gene ADRB1 and familial dilated cardiomyopathy.